Jove
Visualize
お問い合わせ

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

DNGR-1 regulates proliferation and migration of bone marrow dendritic cell progenitors.

The Journal of experimental medicine·2025
Same journal

Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma.

Cancer medicine·2026
Same journal

Microenvironmental Cues That Regulate Cancer Cell Dormancy in Estrogen-Receptor Positive and Triple-Negative Breast Cancer Cell Lines.

Cancer medicine·2026
Same journal

The Association Between Number of Hospital Advanced Practice Providers and Surgical Morbidity.

Cancer medicine·2026
Same journal

Feasibility Study of Combined Systemic Therapy and Carbon-Ion Radiotherapy for Hepatocellular Carcinoma Patients.

Cancer medicine·2026
Same journal

A Prognostic Risk Model Based on Immune Genes in Thyroid Cancer and Its Correlation With Tumor-Associated Immune Cell Infiltration Abundance.

Cancer medicine·2026
Same journal

Robotic Partial Nephrectomy: Different Surgical Approaches for Different Locations.

Cancer medicine·2026
関連記事をすべて見る
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Sep 9, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.4K

癌におけるデンドリット細胞機能の強化

Evangelos Giampazolias1

  • 1Cancer Immunosurveillance Group, Cancer Research UK Manchester Institute, The University of Manchester, Manchester, UK.

Cancer medicine
|August 29, 2025
PubMed
まとめ
この要約は機械生成です。

癌に対するT細胞免疫には,デンドリット細胞 (DCs) が不可欠です. DC機能を理解することで,免疫チェックポイントブロックを含むT細胞ベースのがん免疫療法が改善できます.

キーワード:
T細胞のプリミングアクティベーション抗原の表示がんに対する免疫デンドリット細胞免疫療法

さらに関連する動画

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.6K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

関連する実験動画

Last Updated: Sep 9, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.4K
Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
11:48

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes

Published on: May 31, 2018

11.6K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

科学分野:

  • 免疫学
  • 腫瘍学
  • 細胞生物学

背景:

  • デンドリット細胞 (DCs) は,T細胞の反応を開始する重要な免疫細胞です.
  • DCは抗がん免疫と免疫療法の有効性において重要な役割を果たします.
  • DCは様々な受容体を通して病原体や組織損傷を検出し,抗腫瘍免疫に影響を与えます.

研究 の 目的:

  • dendritic 細胞生物学の基本的な原則をレビューする.
  • ガンにおけるT細胞反応を制御する DCの特徴を強調する.
  • 新しいがん免疫療法に DC機能を活用する方法を探る

主な方法:

  • 樹状細胞生物学とがん免疫学に関する既存の科学文献のレビュー.
  • 抗腫瘍免疫の文脈におけるDCの機能特性の分析
  • 免疫チェックポイントブロックを含むDC機能とT細胞媒介治療の関連性

主要な成果:

  • 癌に対するT細胞免疫を指示するために,デンドリティック細胞は不可欠です.
  • DC受容体のレパートリーと感知能力は,抗腫瘍CD8+T細胞誘導に寄与する.
  • DC機能は,免疫チェックポイント阻害療法に対する反応の強化と関連しています.

結論:

  • 癌の免疫に関する重要な洞察を 提供しています
  • DC機能の活用は 改善されたがん免疫療法の開発に 有望です
  • DCのさらなる理解は,がん患者のT細胞ベースの治療を最適化することができます.